Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
MannKind Corporation logo — Our mission is to give people control of their health and th...

MannKind Corporation

Our mission is to give people control of their health and the freedom to live life.

Founded 1991 United States Danbury, United States 555 employees Post-IPO Debt Biotechnology, Health Care +1

General Information

Company Name MannKind Corporation
Founded Year 1991
Location United States Danbury, United States
Employees 555
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with MannKind Corporation. To contact MannKind Corporation, visit mannkindcorp.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MannKind Corporation compare?

A PDF of MannKind Corporation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MannKind Corporation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) is a biotechnology company focused on developing and commercializing innovative therapeutic products and devices to address unmet medical needs in the fields of endocrine and orphan lung diseases. The company's signature technologies, including dry-powder formulations and inhalation devices, enable the rapid and convenient delivery of medicines directly to the deep lung, offering targeted and effective treatment for conditions such as diabetes, pulmonary arterial hypertension (PAH), and nontuberculous mycobacterial (NTM) lung disease. With a mission to give people control of their health and the freedom to live life, MannKind Corporation is determined to lessen the burden of these debilitating diseases through its formulation capabilities and device engineering prowess. Established in 1991, the company has a passionate team of Mannitarians striving to make a difference in patient care. Headquartered in the United States, MannKind Corporation is positioning itself as a key player in the biotechnology, healthcare, and pharmaceutical industries. For further insights, please visit mannkindcorp.com. As of now, there is no publicly available information regarding the company's last investment and the associated investors. However, with its strong focus on addressing critical medical needs and innovative technologies, MannKind Corporation continues to be an intriguing prospect for potential investors and stakeholders.

No funding data available for MannKind Corporation yet.

FAQ About MannKind Corporation

Our mission is to give people control of their health and the freedom to live life.
MannKind Corporation was founded in 1991.
MannKind Corporation is headquartered in Danbury, United States.
MannKind Corporation operates in Biotechnology, Health Care and Pharmaceutical.
MannKind Corporation has approximately 555 employees.

We're actively collecting intelligence on MannKind Corporation.

Source: BounceWatch company record for MannKind Corporation, https://bouncewatch.com/company/mannkind-corporation, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout